STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

PCRX PACIRA BIOSCIENCES INCORPORATED StockScouter® Report

7

StockScouter® Score

PACIRA BIOSCIENCES INCORPORATED, a small cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
  • The multi-period measure of relative price change and consistency is above average. Positive/Neutral

 

Concerns

  • Short-term relative price momentum exhibits meaningful weakness. Negative
  • Moving average analysis for PCRX suggests downward price movement over the medium term. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 40% done.
Progress: 80% done.
Low
High

Core Model Grades

B
D
C
B

Previous Ratings

4
5
4